Medtronic Q3 in focus amid MedTech gains (NYSE:MDT)

Bloomberg/Bloomberg via Getty Images

Medtronic (NYSE:MDT) is scheduled to report its Q3 FY24 results on Tuesday before the opening bell, with investors expecting another strong quarter from the Dublin, Ireland-based medical device maker as MedTech’s post-pandemic recovery continues.

With their latest financials, MDT’s peers have validated the recent optimism in the sector: Johnson & Johnson (JNJ), Boston Scientific (BSX), Stryker (SYK), and Abbott (ABT) have all either met or exceeded expectations with their Q4 results.

The post Medtronic Q3 in focus amid MedTech gains (NYSE:MDT) first appeared on


Why Retirees Are Confused About Medicare |

Read More | ebri healthcare study For the average American, healthcare in retirement will cost more than they have in their entire savings account. And unfortunately, Medicare won’t help. Healthcare, of course, is the single biggest line item that most retirees need to prepare for. Recently, a study released by the EBRI (the Employee Benefit […]

FAA chief to meet with Boeing in Seattle next week By Reuters |

Read More | © Reuters. Federal Aviation Administration (FAA) Administrator Michael Whitaker testifies before a House Transportation and Infrastructure Aviation Subcommittee hearing to answer questions related to the January 5th rapid depressurization accident involving a Boeing By David Shepardson WASHINGTON (Reuters) -U.S. Federal Aviation Administration chief Michael Whitaker will travel to Seattle early next week […]